On October 16, 2026, the trial registry listed an update for a study involving nesiritide, an unapproved research compound. The trial, titled "High Intensity His Bundle Pacing in Heart Failure Patients With Narrow QRS Outcome Study," is registered under identifier NCT05491655. Its phase is listed as not applicable. The study status has been recorded as completed as of this update date. No phase-specific results or outcome data were included in this update. This brief reflects only the status change reported in the registry entry, not any findings or conclusions. The registry entry does not specify results, efficacy, or safety information related to nesiritide in this context. Readers should note that nesiritide remains classified as an unapproved research compound. No further details on methodology, endpoints, or outcomes were provided in this update. For additional context on this compound, readers can consult the related overview page.
Nesiritide-Linked Trial NCT05491655 Marked Completed as of Oct 2026
See the full nesiritide overview
Source: https://clinicaltrials.gov/study/NCT05491655